House Panel Provides NCI $1.7 Billion for 1991, Expects Greater Emphasis On Cancer Prevention
In Brief: Megastrol Acetate Still Under FDA Review; Mays Hired For NCI’s Technology Office
NCI Announces Designation Of Comprehensive Center
Columbus CCP Forms New Entity to Administer CCOP
Garfinkel to Retire From ACS; Health to Succeed Him
Fox Chase Biochemist Automates DNA Production
Broder Explains Where R01 Money Has Gone
AACR Honorary Memberships; ASCO Awards
Trending Stories
- NIH eliminates the NCI Board of Scientific Advisors
Over its 28 year history, BSA shaped NCI-funded extramural science - Trump administration is removing the mainstays of NCI and the federal government’s cancer program
Peer review, registries, and evidence-based patient information take a big hit - Vinay Prasad, oncologist and Twitter star, locked in debate over precision medicine
- Did Vinay Prasad need to mention the Nazis to make a point on the U.S. pandemic response?
- Cyber-iconoclast Vinay Prasad named head of FDA’s CBER
An oncologist, Prasad has criticized accelerated approval, next-gen sequencing, and targeted therapies - Prasad: FDA has confused merely approving drugs with making the world a better place